Kinetics and Phenotype of Vaccine-Induced CD8+ T-Cell Responses to Toxoplasma gondii

被引:44
|
作者
Jordan, Kimberly A. [1 ]
Wilson, Emma H. [2 ]
Tait, Elia D. [1 ]
Fox, Barbara A. [3 ]
Roos, David S. [4 ]
Bzik, David J. [3 ]
Dzierszinski, Florence [5 ]
Hunter, Christopher A. [1 ]
机构
[1] Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA
[2] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA
[3] Dartmouth Med Sch, Dept Microbiol & Immunol, Lebanon, NH 03756 USA
[4] Univ Penn, Dept Biol, Carolyn Lynch Labs 304B, Philadelphia, PA 19104 USA
[5] McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ H9X 3V9, Canada
关键词
IFN-GAMMA PRODUCTION; MURINE TOXOPLASMOSIS; CD8-T-CELL MEMORY; CD4-T-CELL HELP; LIMITED ROLE; INFECTION; MICE; IMMUNITY; ANTIGEN; LYMPHOCYTES;
D O I
10.1128/IAI.00024-09
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Multiple studies have established that the ability of CD8(+) T cells to act as cytolytic effectors and produce gamma interferon is important in mediating resistance to the intracellular parasite Toxoplasma gondii. To better understand the generation of the antigen-specific CD8(+) T-cell responses induced by T. gondii, mice were immunized with replication-deficient parasites that express the model antigen ovalbumin ( OVA). Class I tetramers specific for SIINFEKL were used to track the OVA-specific endogenous CD8(+) T cells. The peak CD8(+) T-cell response was found at day 10 postimmunization, after which the frequency and numbers of antigen-specific cells declined. Unexpectedly, replication-deficient parasites were found to induce antigen-specific cells with faster kinetics than replicating parasites. The generation of optimal numbers of antigen-specific CD8(+) effector T cells was found to require CD4(+) T-cell help. At 7 days following immunization, antigen-specific cells were found to be CD62L(low), KLRG1(+), and CD127(low), and they maintained this phenotype for more than 70 days. Antigen-specific CD8(+) effector T cells in immunized mice exhibited potent perforin-dependent OVA-specific cytolytic activity in vivo. Perforin-dependent cytolysis appeared to be the major cytolytic mechanism; however, a perforin-independent pathway that was not mediated via Fas-FasL was also detected. This study provides further insight into vaccine-induced cytotoxic T-lymphocyte responses that correlate with protective immunity to T. gondii and identifies a critical role for CD4(+) T cells in the generation of protective CD8(+) T-cell responses.
引用
收藏
页码:3894 / 3901
页数:8
相关论文
共 50 条
  • [1] Rapamycin Impairs Antitumor CD8+ T-cell Responses and Vaccine-Induced Tumor Eradication
    Chaoul, Nada
    Fayolle, Catherine
    Desrues, Belinda
    Oberkampf, Marine
    Tang, Alexandre
    Ladant, Daniel
    Leclerc, Claude
    CANCER RESEARCH, 2015, 75 (16) : 3279 - 3291
  • [2] Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses
    Simona Stäger
    James Alexander
    Alun C Kirby
    Marina Botto
    Nico Van Rooijen
    Deborah F Smith
    Frank Brombacher
    Paul M Kaye
    Nature Medicine, 2003, 9 : 1287 - 1292
  • [3] Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses
    Stäger, S
    Alexander, J
    Kirby, AC
    Botto, M
    Van Rooijen, N
    Smith, DF
    Brombacher, F
    Kaye, PM
    NATURE MEDICINE, 2003, 9 (10) : 1287 - 1292
  • [4] Enhancement of Vaccine-induced Primary and Memory CD8+ T-cell Responses by Soluble PD-1
    Song, Mi-Young
    Park, Sang-Hoon
    Nam, Hyo Jung
    Choi, Dong-Hoon
    Sung, Young-Chul
    JOURNAL OF IMMUNOTHERAPY, 2011, 34 (03) : 297 - 306
  • [5] CD8+ T Cell Responses to Toxoplasma gondii: Lessons from a Successful Parasite
    Tsitsiklis, Alexandra
    Bangs, Derek J.
    Robey, Ellen A.
    TRENDS IN PARASITOLOGY, 2019, 35 (11) : 887 - 898
  • [6] Agonist anti-GITR antibody enhances vaccine-induced CD8+ T-cell responses and tumor immunity
    Cohen, AD
    Diab, A
    Perales, MA
    Wolchok, JD
    Rizzuto, G
    Merghoub, T
    Huggins, D
    Liu, CL
    Turk, MJ
    Restifo, NP
    Sakaguchi, S
    Houghton, AN
    CANCER RESEARCH, 2006, 66 (09) : 4904 - 4912
  • [7] Vaccine-induced CD8+ T-cell responses to MAGE-3 correlate with clinical outcome in patients with melanoma
    Reynolds, SR
    Zeleniuch-Jacquotte, A
    Shapiro, RL
    Roses, DF
    Harris, MN
    Johnston, D
    Bystryn, JC
    CLINICAL CANCER RESEARCH, 2003, 9 (02) : 657 - 662
  • [8] Optimizing vaccine-induced CD8+ T-cell immunity: focus on recombinant adenovirus vectors
    Bassett, Jennifer D.
    Swift, Stephanie L.
    Bramson, Jonathan L.
    EXPERT REVIEW OF VACCINES, 2011, 10 (09) : 1307 - 1319
  • [9] CD8+ T-CELL IMMUNITY TO TOXOPLASA GONDII
    KASPER, LH
    ELY, K
    KHAN, IA
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 80 - 80
  • [10] Functional heterogeneity of vaccine-induced CD8+ T cells
    Monsurrò, V
    Nagorsen, D
    Wang, E
    Provenzano, M
    Dudley, ME
    Rosenberg, SA
    Marincola, FM
    JOURNAL OF IMMUNOLOGY, 2002, 168 (11): : 5933 - 5942